Searchable abstracts of presentations at key conferences in endocrinology

ea0010p92 | Thyroid | SFE2005

Acute intermittent porphyria associated with inappropriate ADH secretion and hyperthyroidism

Ashawesh K , Jones M

Acute intermittent porphyria (AIP) is an autosomal dominant disease due to deficient Porphobilinogen (PBG) deaminase activity. Hyponatremia, found in approximately 20% of symptomatic AIP, is often due to inappropriate ADH secretion (SIADH). An association between AIP and hyperthyroidism is not clearly established. We describe a patient with AIP and SIADH who presented with GravesÂ’ hyperthyroidism. A 35-year-old lady was admitted with lower abdominal pain. Physical examina...

ea0009p33 | Diabetes and metabolism | BES2005

Testosterone does not promote A7r5 rat aortic vascular smooth muscle cell growth

Kerry K , Jones R , Channer K , Jones T

Vascular smooth muscle cells (VSMC) form a major constituent of the atherosclerotic plaque providing structural stability. However, increased cell number due to high proliferation rates can lead to greater artery occlusion. Testosterone replacement therapy improves exercise capacity and reduces symptoms of angina in men with coronary artery disease, although its effect upon VSMC growth is currently unknown. Testosterone deficiency is associated with increased atheroma burden a...

ea0009p35 | Diabetes and metabolism | BES2005

Study of the effect of testosterone upon apoptosis in the rat aortic A7r5 vascular smooth muscle cell line

Kerry K , Jones R , Channer K , Jones T

Several studies have demonstrated that atherosclerosis is associated with low serum levels of testosterone and replacement therapy reduces myocardial ischaemia in men. Vascular smooth muscle cell (VSMC) apoptosis reduces plaque stability. The role of testosterone if any, in this process is unknown. Testosterone has been demonstrated act via both the classic androgen receptor and by calcium channel antagonism. Calcium channel blockers have been shown to induce VSMC apoptosis. W...

ea0005oc13 | Cardiovascular Endocrinology | BES2003

Assessment of the vasodilatory action of testosterone in isolated human pulmonary and mesenteric arteries and veins

Rowell K , Jones R , Pugh P , Channer K , Jones T

Testosterone therapy has been shown to benefit men with heart failure or coronary artery disease, an activity proposed to be mediated via its vasodilatory efficacy. Testosterone has been demonstrated to dilate human coronary arteries, but it is unknown whether testosterone has a similar action in human pulmonary or systemic vessels.Male patients were recruited from cardiothoracic (n = 14, age = 68 plus/minus 9) or gastrointestinal (n = 8, age = 70 plus/minus 3) operating l...

ea0013p69 | Clinical practice/governance and case reports | SFEBES2007

Successful management of a patient with a carcinoid tumour through 2 major operations using Octreotide – A case report

Sukesh Chandran K , Jones Steven

69-year-old male with background of hypertension and dyslipidaemia was admitted to ENT with a food bolus obstruction. CXR on admission revealed a well-defined mass in the right lower lobe consistent with lung cancer. Oesophagoscopy revealed a narrowing level secondary to external compression. A staging CT of chest and abdomen confirmed a mass on the right base invading the main right lower lobe bronchus. Incidentally there was an 8 cm infra renal abdominal aortic aneurysm. The...

ea0029p270 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Effect of testosterone on hepatic liver X receptor and ApoE expression as a potential mechanism of atheroprotection in the testicular feminised mouse

Kelly D. , Akhtar S. , Brooke J. , Channer K. , Jones T.

Testosterone deficiency is associated with several cardiovascular risk factors. Testosterone replacement therapy (TRT) improves insulin sensitivity, inflammation and cholesterol. Liver X receptor (LXR) is a nuclear receptor which regulates lipid and glucose metabolism, stimulates cholesterol efflux and ApoE, and suppresses inflammation. LXR agonists cause hepatic steatosis but protect against atherosclerosis. TRT attenuates high-cholesterol diet-induced hepatic steatosis in th...

ea0029p559 | Diabetes | ICEECE2012

Low testosterone is associated with decreased expression of glut-4 and hexokinase 2 in muscle of the testicular feminised mouse

McLaren D , Kelly D , Akhtar S , Channer K , Jones T

Testosterone deficiency is a common in men with type two diabetes (T2D). We have shown testosterone replacement therapy (TRT) improves insulin resistance and glycaemic control. The mechanisms by which testosterone mediates this action are unknown but may be due to a combination of effects on muscle, liver and adipose tissues. This study investigates the expression of Glut4 and HK2, (two key proteins involved in insulin sensitivity) in muscle tissue of the testicular feminised ...

ea0029p979 | Female Reproduction | ICEECE2012

Effects of dopamine agonist administration during seasonal cyclicity in the mare

King S. , Bass C. , Roser J. , Murphy L. , Jones K.

Prolactin is associated with seasonal transitions into and out of anestrus in the mare. The earliest anestrous transitional changes are declining progesterone secretion and a concomitant prolactin decline. Ovarian changes include slowed follicular development and prolonged luteal activity. Dopamine antagonist administration during the autumnal transition prevented a seasonal progesterone decline, suggesting a cause-and-effect between prolactin and progesterone production. The ...

ea0019p13 | Bone | SFEBES2009

Hyperparathyroidism secondary to a parathyroid carcinoma

Chikkaveerappa K , Jones IA , Wynne S , Leong KS

We present a rare case of hypercalcaemia caused by a parathyroid carcinoma.An asymptomatic 74 year old gentleman was referred with slightly raised alkaline phosphatase and corrected serum calcium the results of which are shown below:Serum Calcium 3.02 mmol/l, Albumin 41 g/l, PTH 18.7 pmol/l, Urine Calcium 10.6 mmol/24 h, TSH 6.3 Mu/l, FT4 12.3 pmol/l, FT3 5.1 pmol/l, TPO antibody >5000 IU/ml, ALP 142 iu/l.<p class="abstext"...

ea0019p160 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Activating androgen receptor CAG and GGN polymorphisms and low total testosterone are associated with lower HDL cholesterol in men with type 2 diabetes

Stanworth R , Kapoor D , Channer K , Jones H

Background: Low testosterone levels are a common finding in men with type 2 diabetes and are also associated with low HDL cholesterol (HDL-C) levels which are an independent risk factor for cardiovascular disease. The androgen receptor CAG repeat polymorphism (AR CAG) and GGN repeat polymorphism (AR GGN) affect receptor function such that shorter AR CAG and AR GGN=23 are associated with greater transcriptional activity in vitro.Methods and results...